Epidermal growth factor receptor regulates Beclin-1 in hyperoxic acute lung injury

Read full text
Authors: Zachary M Harris, Asawari Korde, Johad Khoury, Edward P. Manning, Gail Stanley, Yosep Shin, Kennedy Mitchell, Alexa von der Schulenburg, Ying Sun, Buqu Hu, Hyeon Jun Shin, John Joerns
+12 more Brian Clark, Lindsey Placek, Derya Unutmaz, Aigul Moldobaeva, Lokesh Sharma, Maor Sauler, Govindarajan Rajagopalan, Xuchen Zhang, He Wang, Mahboobe Ghaedi, Min‐Jong Kang, Jonathan L Koff
Cited by: 1
References: 103

Abstract

Background While delivery of supplemental oxygen is a life-saving therapy, exposure to high oxygen, called hyperoxia, leads to increased intensive care unit mortality. Hyperoxia induces oxidant-mediated acute lung injury (ALI) and pulmonary cell death, called hyperoxic ALI (HALI). Elucidating molecular mechanisms in HALI could identify therapeutic targets in ALI. Methods In the current study, we examined in vivo effects of HALI on Beclin-1 (BCN1), which regulates autophagy, and modulation of BCN1 by epidermal growth factor receptor (EGFR). Effects of HALI on BCN1 and autophagy were examined in mice with genetically decreased EGFR (EGFR Wa5/+ ). Wildtype (WT) and EGFR Wa5/+ mice were exposed to 100% oxygen for 24–72 hours along with normoxia controls (eight groups; n=4–6/group), and analysis of pulmonary BCN1 and autophagy was completed. Results In WT, HALI led to increased BCN1 (59% increased total BCN1/β-Actin; p

Fields of Study & Subjects

Autophagy in Disease and Therapy Connective tissue disorders research Peptidase Inhibition and Analysis

Publication details

Journal / source
BMJ Open Respiratory Research
Publisher
BMJ
Volume
13
Issue
1
Pages
e003323–e003323
Publication date
1 January 2026
Language
EN